As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.
Proposals must be appropriate to the emergency situation and, therefore, allow immediate implementation and start-up in the National Health System, with concrete, early results applicable to the current situation.
Projects should be able to be quickly implemented and focus on increasing supplies of products to deal with the pandemic, vaccines, improving COVID-19 treatment and diagnosis, and new public health measures.
Support to enable existing projects to address prevention, diagnosis, treatment, supply of critical resources and other issues facing the COVID-19 crisis.
Amount
$500,000 (U.S. dollars)
Agency or Funder
Patient-Centered Outcomes Research Institute (PCORI)
Eligibility (if available)
Principal investigators already receiving grants from the PCORI
Research projects for potential treatments, techniques and datasets will be prioritised according to their impact on public health. Preference will be given to projects that plan to make their datasets publicly available and referenceable.
Amount
$5.000 (U.S.) in GCP credits. PhD awards $1,000 (U.S.)
Agency or Funder
Google
Eligibility (if available)
A commercial, nonprofit, government or academic research institution based in a country where Google Credits Program credits are approved.
An invitation to contribute to the understanding of the COVID-19 epidemic in Bolivia and its impact on mental health, food security, the economy, and education.
Amount
Decided on a case by case basis
Agency or Funder
Universidad Autónoma Gabriel René Moreno
Eligibility (if available)
Researchers at the Universidad Autónoma Gabriel René Moreno
Funding for existing PCORI-funded projects that wish to adapt or alter their original aims to produce useful knowledge or research related to COVID-19.
Amount
Up to $150.000 (U.S.)
Agency or Funder
Patient-Centered Outcomes Research Institute (PCORI)
Eligibility (if available)
Only PCORI-funded project leads with active Engagement Award contracts are eligible
Proposals should include test kits, respiratory devices, protective equipment or mobile applications for detection, tracing, and information sharing, that can respond to the current emergency medical needs for Lebanon.
Research is to focus on vaccines and therapeutics; and on diagnostics, clinical investigations, anthropology investigations, and development of technologies, platforms or systems to accelerate the R&D of diagnostics.
Amount
£20M
Agency or Funder
National Institute for Health Research
Eligibility (if available)
Hosted by a UK institution eligible for UKRI funding. Overseas research organisations in affected countries providing important local engagement can be co-investigators
Any aspect of coronavirus research. Applicants may request up to 300,000 francs for projects lasting up to 24 months. Bigger grants are conceivable, provided the applicant has good reasons for requesting a higher amount.
A special call specifically designed for COVID-19 and related respiratory viral infections to ramp up national R&D efforts for new antivirals, vaccines, and affordable diagnostics.
Amount
Not specified
Agency or Funder
Science & Engineering Research Board, India
Eligibility (if available)
One of the participating institutions should have access to Biosafety Level 3 and above facilities, along with expertise of handling respiratory viruses as per WHO/Govt. of India protocols.
Development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak; therapeutics to address the current and/or future coronavirus outbreaks; diagnostics, ensuring rapid evaluation of candi
Funding for universities, technologists and researchers with innovative proposals, including seed funding, to provide solutions applicapel to the COVID-19 pandemic.